{"@context":"https://schema.org","@type":"Legislation","name":"Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019","description":"

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs.

Among other programs, the bill reauthorizes through FY2023 and revises

the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC),
the Hospital Preparedness Program,
the CDC situational-awareness and biosurveillance program,
the Emergency System for Advance Registration of Volunteer Health Professionals,
the National Disaster Medical System,
the Volunteer Medical Reserve Corps,
the National Advisory Committee on Children and Disasters,
the Strategic National Stockpile, and
the Biomedical Advanced Research and Development Authority.

In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams.

The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.

","legislationIdentifier":"HR 269","legislationType":"Bill","legislationLegalForce":"NotInForce","legislationJurisdiction":"USA","author":[{"@type":"Person","name":"Anna G. Eshoo","url":"https://legisdaily.com/mp/annag-eshoo-us"}],"about":{"@type":"Thing","name":"Health"},"keywords":"Administrative law and regulatory procedures, Advanced technology and technological innovations, Advisory bodies, Aging, Blood and blood diseases, Border security and unlawful immigration, Centers for Disease Control and Prevention (CDC), Chemical and biological weapons, Child health, Child safety and welfare, Computer security and identity theft, Congressional oversight, Consumer affairs, Disability and paralysis, Disaster relief and insurance, Drug safety, medical device, and laboratory regulation, Emergency communications systems, Emergency medical services and trauma care, Emergency planning and evacuation, Environmental health, First responders and emergency personnel, Food and Drug Administration (FDA), General health and health care finance matters, Genetics, Government employee pay, benefits, personnel management, Government information and archives, Government liability, Hazardous wastes and toxic substances, Health facilities and institutions, Health information and medical records, Health personnel, Health programs administration and funding, Health promotion and preventive care, Health technology, devices, supplies, Homeland security, Hospital care, Immunology and vaccination, Infectious and parasitic diseases, Infrastructure development, Intelligence activities, surveillance, classified information, Intergovernmental relations, Judicial review and appeals, Licensing and registrations, Marketing and advertising, Medical research, Military medicine, Minority health, Musculoskeletal and skin diseases, Natural disasters, Performance measurement, Prescription drugs, Research and development, Social work, volunteer service, charitable organizations, State and local government operations, Technology assessment, Terrorism, User charges and fees, Veterinary medicine and animal diseases, Women's health, World health","dateModified":"2025-05-28T00:00:00.000Z","url":"https://legisdaily.com/bill/USA-116-HR-269"}

Anna G. Eshoo

Homeland Security Committee, Veterans' Affairs Committee, Judiciary Committee, Energy and Commerce Committee

Anna G. Eshoo

Homeland Security Committee, Veterans' Affairs Committee, Judiciary Committee, Energy and Commerce Committee